GO:0061886 negative regulation of mini excitatory postsynaptic potential

Miniature excitatory postsynaptic potentials (mEPSCs) are small, spontaneous depolarizations that occur when a single vesicle of excitatory neurotransmitter is released at a synapse. They are recorded electrophysiologically and are widely used to probe synaptic function: mEPSC frequency is generally interpreted as a proxy for presynaptic release probability, whereas mEPSC amplitude reflects postsynaptic receptor abundance and sensitivity. The Gene Ontology term GO:0061886, negative regulation of mini excitatory postsynaptic potential, captures any biological process that decreases the frequency, rate, or extent of these events. Understanding this term is important because altered mEPSC regulation is observed in neuropsychiatric and neurological conditions, and because it provides a quantitative framework for linking molecular perturbations to synaptic phenotypes. In practice, researchers study GO:0061886 by combining electrophysiology with genetic, pharmacological, and molecular tools to determine whether a candidate gene or pathway suppresses spontaneous excitatory transmission. This article summarizes the definition, mechanisms, key genes, disease relevance, and research methods for GO:0061886, with all factual claims supported by the verified citation.

GO:0061886, negative regulation of mini excitatory postsynaptic potential, is a biological process that decreases the frequency, rate, or extent of miniature excitatory postsynaptic potentials (mEPSCs). An mEPSC is a temporary increase in postsynaptic potential caused by positively charged ions flowing into the postsynaptic cell after spontaneous release of a single vesicle of excitatory neurotransmitter. In other words, this GO term covers any cellular mechanism that reduces how often or how strongly these spontaneous miniature excitatory events occur.

GO:0061886 matters because miniature excitatory postsynaptic potentials are a fundamental readout of synaptic transmission, and their negative regulation directly influences information processing in neural circuits. Changes in mEPSC frequency or amplitude can alter network excitability, synaptic plasticity, and behavior, and have been implicated in neuropsychiatric disorders such as addiction and stress-related conditions. Studying this process helps researchers distinguish presynaptic versus postsynaptic mechanisms of synaptic modulation and identify molecular targets for therapeutic intervention.

The following genes and proteins have been implicated in mechanisms related to negative regulation of mini excitatory postsynaptic potential, based on the verified citation.

Negative regulation of mEPSC is itself regulated by neuromodulatory systems. For example, kappa-opioid receptor activation in prefrontal cortex modulates local neurotransmission and can decrease mEPSC frequency, demonstrating that GPCR signaling pathways regulate this process. This regulation can be studied using pharmacological agonists/antagonists and genetic manipulations of receptors and downstream effectors.

Altered mEPSC regulation has been observed in models of conditioned place aversion and stress-related behaviors, where kappa-opioid receptor modulation in prefrontal cortex plays a role. Negative regulation of mEPSC may contribute to synaptic changes underlying addiction and mood disorders.

Kappa-opioid receptor signaling, which can negatively regulate mEPSC, is implicated in stress responses and aversive behaviors. Dysregulation of this process may contribute to stress-related psychiatric conditions.

Because mEPSC frequency and amplitude reflect fundamental synaptic properties, genes involved in negative regulation of mEPSC may be relevant to broader neurological and psychiatric conditions, although specific disease links require further study.

Whole-cell patch-clamp recordings measure mEPSC frequency and amplitude, providing direct functional readout of negative regulation of mEPSC.

Application of receptor agonists or antagonists, such as kappa-opioid receptor ligands, can test whether a pathway negatively regulates mEPSC.

Knockout, knock-in, or overexpression of candidate genes followed by electrophysiology can establish causal roles in negative regulation of mEPSC.

Fluorescent tagging of synaptic proteins and imaging can reveal changes in release sites or receptor clustering that underlie mEPSC regulation.

Researchers studying negative regulation of mini excitatory postsynaptic potential-related genes often need to determine whether a candidate gene is causally involved in suppressing spontaneous excitatory transmission. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models for such investigations.

GO:0061886, negative regulation of mini excitatory postsynaptic potential, is a key biological process that controls spontaneous excitatory synaptic transmission. Understanding its mechanisms, key genes, and disease relevance provides a foundation for neuropsychiatric research and therapeutic development. CRISPR-based models and advanced electrophysiological methods offer powerful tools to dissect this process and identify new regulatory pathways.